{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:41:04Z","timestamp":1791009664035,"version":"4.1.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1097\/01.coc.0000227481.36109.e7","type":"journal-article","created":{"date-parts":[[2006,7,21]],"date-time":"2006-07-21T04:45:33Z","timestamp":1153457133000},"page":"336-344","source":"Crossref","is-referenced-by-count":39,"title":["Systemic Treatment of Malignant Thymoma"],"prefix":"10.1097","volume":"29","author":[{"given":"Giuseppe","family":"Giaccone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanneke","family":"Wilmink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marinus A.","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210128","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jso.10231","article-title":"Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution.","volume":"83","author":"Takeda","year":"2003","journal-title":"J Surg Oncol"},{"key":"R2-3-20210128","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00277-002-0597-6","article-title":"Malignant thymoma: current status of classification and multimodality treatment.","volume":"82","author":"Schmidt-Wolf","year":"2003","journal-title":"Ann Hematol"},{"key":"R3-3-20210128","article-title":"Histological Typing of Tumors of the Thymus, 2nd ed.","author":"Rosai","year":"1999"},{"key":"R4-3-20210128","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1097-0142(19860801)58:3<765::AID-CNCR2820580326>3.0.CO;2-S","article-title":"Thymomas. A review of 169 cases, with particular reference to results of surgical treatment.","volume":"58","author":"Maggi","year":"1986","journal-title":"Cancer"},{"key":"R5-3-20210128","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1200\/JCO.1999.17.7.2280","article-title":"Thymoma: state of the art.","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"R6-3-20210128","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0360-3016(92)90911-Z","article-title":"Thymoma: treatment and prognosis.","volume":"23","author":"Pollack","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R7-3-20210128","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/ijc.11099","article-title":"Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies.","volume":"105","author":"Engels","year":"2003","journal-title":"Int J Cancer"},{"key":"R8-3-20210128","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1016\/S0003-4975(03)01020-8","article-title":"Long-term outcome after multimodality treatment for stage III thymic tumors.","volume":"76","author":"Venuta","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R9-3-20210128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/01.cco.0000152628.43867.8e","article-title":"Treatment of malignant thymoma.","volume":"17","author":"Giaccone","year":"2005","journal-title":"Curr Opin Oncol"},{"key":"R10-3-20210128","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/bjc.1996.157","article-title":"PET imaging of primary mediastinal tumours.","volume":"73","author":"Kubota","year":"1996","journal-title":"Br J Cancer"},{"key":"R11-3-20210128","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1200\/JCO.1997.15.9.3093","article-title":"Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: an intergroup trial.","volume":"15","author":"Loehrer","year":"1997","journal-title":"J Clin Oncol"},{"key":"R12-3-20210128","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R13-3-20210128","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1002\/1097-0142(20010601)91:11<2010::AID-CNCR1226>3.0.CO;2-2","article-title":"Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma: an intergroup trial.","volume":"91","author":"Loehrer","year":"2001","journal-title":"Cancer"},{"key":"R14-3-20210128","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/1097-0142(19910701)68:1<30::AID-CNCR2820680106>3.0.CO;2-4","article-title":"Chemotherapy for invasive thymoma. A 13-year experience.","volume":"68","author":"Fornasiero","year":"1991","journal-title":"Cancer"},{"key":"R15-3-20210128","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1200\/JCO.2004.02.047","article-title":"Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: an Eastern Cooperative Oncology Group Phase II Trial.","volume":"22","author":"Loehrer","year":"2004","journal-title":"J Clin Oncol"},{"key":"R16-3-20210128","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1634\/theoncologist.6-3-239","article-title":"Thymoma: update for the new millennium.","volume":"6","author":"Johnson","year":"2001","journal-title":"Oncologist"},{"key":"R17-3-20210128","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1200\/JCO.1996.14.3.814","article-title":"Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.","volume":"14","author":"Giaccone","year":"1996","journal-title":"J Clin Oncol"},{"key":"R18-3-20210128","first-page":"695","article-title":"Cisplatin-containing chemotherapy in the treatment of invasive thymoma: report of five cases.","volume":"69","author":"Giaccone","year":"1985","journal-title":"Cancer Treat Rep"},{"key":"R19-3-20210128","first-page":"447","article-title":"Chemotherapy of thymomas and thymic carcinomas.","volume":"11","author":"Chahinian","year":"2001","journal-title":"Chest Surg Clin North Am"},{"key":"R20-3-20210128","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. The Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group.","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"R21-3-20210128","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2003.11.021","article-title":"Thymic carcinoma: state of the art review.","volume":"59","author":"Eng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R22-3-20210128","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.lungcan.2003.12.010","article-title":"Phase II study of a multidisciplinary approach with induction chemotherapy, followed by surgical resection, radiation therapy, and consolidation chemotherapy for unresectable malignant thymomas: final report.","volume":"44","author":"Kim","year":"2004","journal-title":"Lung Cancer"},{"key":"R23-3-20210128","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2559.2004.01796.x","article-title":"Thymic carcinoma: a clinicopathological and immunohistological study of 19 cases.","volume":"44","author":"Chalabreysse","year":"2004","journal-title":"Histopathology"},{"key":"R24-3-20210128","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/jjco\/hye136","article-title":"Chemotherapy of thymic carcinoma: analysis of seven cases and review of the literature.","volume":"31","author":"Kitami","year":"2001","journal-title":"Jpn J Clin Oncol"},{"key":"R25-3-20210128","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/S0003-4975(03)00831-2","article-title":"Thymic carcinoma: involvement of great vessels indicates poor prognosis.","volume":"76","author":"Tseng","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R26-3-20210128","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan.","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"R27-3-20210128","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/01.coc.0000046301.83671.09","article-title":"Multimodality therapy for thymic carcinoma (TCA): results of a 30-year single-institution experience.","volume":"27","author":"Hernandez-Ilizaliturri","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"R28-3-20210128","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/ejso.2001.1197","article-title":"Thymic carcinoma: a report of 13 cases.","volume":"27","author":"Lucchi","year":"2001","journal-title":"Eur J Surg Oncol"},{"key":"R29-3-20210128","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0022-5223(03)00798-0","article-title":"Thymoma: a clinicopathologic study based on the new World Health Organization classification.","volume":"126","author":"Nakagawa","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"R30-3-20210128","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0002-9440(10)64536-1","article-title":"Recurrent genetic aberrations in thymoma and thymic carcinoma.","volume":"157","author":"Zettl","year":"2000","journal-title":"Am J Pathol"},{"key":"R31-3-20210128","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/cncr.10374","article-title":"Somatostatin analogs and prednisone in advanced refractory thymic tumors.","volume":"94","author":"Palmieri","year":"2002","journal-title":"Cancer"},{"key":"R32-3-20210128","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00432-004-0545-z","article-title":"Tyrosine kinase receptor expression in thymomas.","volume":"130","author":"Henley","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"R33-3-20210128","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.128.1.140","article-title":"Immunohistochemical KIT (CD117) expression in thymic epithelial tumors.","volume":"128","author":"Nakagawa","year":"2005","journal-title":"Chest"},{"key":"R34-3-20210128","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1056\/NEJM200406173502523","article-title":"Thymic carcinoma with overexpression of mutated KIT and the response to imatinib.","volume":"350","author":"Strobel","year":"2004","journal-title":"N Engl J Med"},{"key":"R35-3-20210128","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/path.1514","article-title":"KIT (CD117) is frequently overexpressed in thymic carcinomas but is absent in thymomas.","volume":"202","author":"Pan","year":"2004","journal-title":"J Pathol"},{"key":"R36-3-20210128","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R","article-title":"Follow-up study of thymomas with special reference to their clinical stages.","volume":"48","author":"Masaoka","year":"1981","journal-title":"Cancer"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00000421-200608000-00003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T15:41:42Z","timestamp":1785858102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00000421-200608000-00003"}},"subtitle":["A Decade Experience at a Single Institution"],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.coc.0000227481.36109.e7","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}